EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine

Qi Li, Jingyi Yang, Daozhen Chen, Yu Chen iD, Sunmin Jiang

International Journal of Nanomedicine · 2026-07 · Volume 21 · 1-21

DOI: 10.2147/ijn.s626371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-07. Verfasst von Qi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Women's Hospital of Jiangnan University, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Immunotherapy, Lipid Metabolism, Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the clinical success of immune checkpoint inhibitors (ICIs), resistance driven by a metabolically hostile tumor microenvironment (TME), particularly lipid metabolic reprogramming, remains a formidable challenge. Tumors actively exploit lipid mediators, notably prostaglandin E2 (PGE2), to suppress CD8 + T cells and promote immunosuppressive macrophage polarization. Although targeted nanotherapeutics aim to locally reverse these defects, their in vivo efficacy is frequently abrogated by the host’s nutritional baseline. Specifically, high dietary intake of Omega-6 polyunsaturated fatty acids fuels systemic PGE2 biosynthesis, creating a metabolic “sink” that localized nanotherapies struggle to neutralize. To address this limitation, this review proposes a dual-compartment therapeutic framework combining systemic dietary modulation with precision nanotherapy. As a distinctive contribution, we bridge these biological mechanisms with pharmaceutical design by integrating critical translational barriers, advanced formulation strategies, and emerging technologies for lipid reprogramming. Building upon this, we critically evaluate the most promising formulations, including stimuli-responsive and lipid-targeted nanocarriers, to elucidate their synergistic potential with nutritional interventions. Ultimately, pairing systemic Omega-3 dietary preconditioning with localized nanotherapeutics provides a biologically rational strategy to dismantle lipid-driven immune evasion. Maximizing patient outcomes and advancing future clinical prospects will depend on the rigorous translation of these combinatorial regimens to effectively overcome ICI resistance. Keywords: metabolic immunotherapy, immunotherapy resistance, lipid metabolic reprogramming, nanotherapeutics, omega-3 fatty acids

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyLipid MetabolismNeoplasmsHumansMetabolic ReprogrammingNanomedicineAnimalsFatty Acids, Omega-3Tumor MicroenvironmentPrecision MedicineImmune Checkpoint InhibitorsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

immunotherapy resistancelipid metabolic reprogrammingmetabolic immunotherapynanotherapeuticsomega-3 fatty acids

Substanzen

Fatty Acids, Omega-3Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Affiliated Women's Hospital of Jiangnan University, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
  • Wuxi Higher Health Vocational Technology School, Wuxi, Jiangsu, People's Republic of China.

ORCID-Profile: Yu Chen

Zitieren

APA

Li, Q., Yang, J., Chen, D., Chen, Y., & Jiang, S. (2026). Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine. International Journal of Nanomedicine, Volume 21, 1-21. https://doi.org/10.2147/ijn.s626371

Vancouver

Li Q, Yang J, Chen D, Chen Y, Jiang S. Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine. International Journal of Nanomedicine. 2026;Volume 21:1-21. doi:10.2147/ijn.s626371

BibTeX
@article{Li2026,
  author = {Li, Qi and Yang, Jingyi and Chen, Daozhen and Chen, Yu and Jiang, Sunmin},
  title = {Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--21},
  doi = {10.2147/ijn.s626371}
}
Kostenlos starten →